Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $7.1400 (-6.79%) ($6.3400 - $7.4500) on Wed. Mar. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.83% (three month average) | RSI | 31 | Latest Price | $7.1400(-6.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -6.9% a day on average for past five trading days. | Weekly Trend | TGTX declines -22.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(66%) ARKG(61%) IBB(59%) ARKK(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -2.915% in a week (0% probabilities). VIXM(-41%) VXX(-39%) UUP(-7%) TLT(-6%) IGOV(1%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.915% (StdDev 5.83%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
1 - 5 Day Possible Target | $-28.98(-505.88%) | Resistance Level | $11.64 | 5 Day Moving Average | $7.81(-8.58%) | 10 Day Moving Average | $9.44(-24.36%) | 20 Day Moving Average | $11.64(-38.66%) | To recent high | -55.3% | To recent low | 0% | Market Cap | $904m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |